IL17A and neoplasm: Within the bcl-2-driven protumor reprogramming, IL-1β acts as critical upstream regulator of tumor growth and macrophage functions, since its neutralization decreased the expression of COX-2 and IL-17, as well as expression of M2 polarization markers by macrophages.